LMR Partners LLPLMR Partners LLP

Institutional investor · Portfolio as of Q4 2019

SEC EDGAR SourceSEC Filings

Top Holdings391 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
??CAESARS ENTMT CORPDelisted
Bond
50M$9.6B15.7%
1 qtr
New
98
??CLEVELAND-CLIFFS INCDelisted
Bond
26.6M$3.2B5.2%
1 qtr
New
98
??TESLA INCDelisted
Bond
21.5M$3.1B5.0%
1 qtr
New
98
35M$3B5.0%
1 qtr
New
88
??ISTAR INCDelisted
Bond
25M$2.8B4.6%
1 qtr
New
88
??MEDICINES CODelisted
Bond
10M$2.5B4.2%
1 qtr
New
88
49M$2.4B4.0%
1 qtr
New
88
??TWITTER INCDelisted
Bond
25M$2.4B4.0%
1 qtr
New
88
24.2M$2.3B3.8%
1 qtr
New
88
??DEXCOM INCDelisted
Bond
10M$2.2B3.6%
1 qtr
New
88
??TESLA INCDelisted
Bond
14.5M$2.2B3.6%
1 qtr
New
88
??CTRIP COM INTL LTDDelisted
Bond
20M$2B3.2%
1 qtr
New
88
10M$1.9B3.2%
1 qtr
New
88
14M$1.9B3.0%
1 qtr
New
88
??LUMENTUM HLDGS INCDelisted
Bond
12.5M$1.8B3.0%
1 qtr
New
83
??MEDICINES COMPANYDelisted
Bond
10M$1.7B2.9%
1 qtr
New
83
??TWILIO INCDelisted
Bond
10M$1.5B2.5%
1 qtr
New
83
??MESA LABORATORIES INCDelisted
Bond
12.5M$1.4B2.2%
1 qtr
New
83
??GDS HOLDINGS LIMITEDDelisted
Bond
11.3M$1.4B2.2%
1 qtr
New
83
??SCORPIO TANKERS INCDelisted
Bond
11M$1.4B2.2%
1 qtr
New
83
$61.1B
AUM
391
Positions
Q4 2019
Filing
Rating · 3.5
Quarterly Portfolio Change
+40%Q2'19$2.7B-26%Q3'19$2B+2921%Q4'19$61.1B
Activity profile
$ moved · Q4'19
New98%Increased0%Decreased0%Exited2%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.7 quarters
<1Q34%1-4Q64%1-2Y0%2Y+2%

LMR Partners LLP manages $61.1B across 391 positions as of Q4 2019. Top holdings: CAESARS ENTMT CORP (15.7%), CLEVELAND-CLIFFS INC (5.2%), TESLA INC (5.0%). Fund DNA: Diversified Scout. HoldingsIntel Rating: 3.5/5.0.

Q4 2019 Summary

Active quarter - 236 new positions, 261 exits, 62 increased. No standout high-conviction moves this quarter. Portfolio: $61.1B across 391 positions.

Top holdings by portfolio weight

Total AUM$61B
CAESARS ENTM15.74%
CLEVELAND-CL5.22%
TESLA INC5.00%
LIBERTY INTE4.99%
ISTAR INC4.62%
MEDICINES CO4.15%
CHESAPEAKE E4.01%
TWITTER INC3.98%
TEVA PHARMAC3.79%
DEXCOM INC3.65%
Other3.59%

Portfolio allocation by GICS sector

Sectors11
Financial Services28.92%
Technology18.79%
Unknown16.75%
Healthcare8.45%
Consumer Cyclical7.73%
Communication Services4.29%
Industrials4.21%
Basic Materials3.60%
Real Estate3.57%
Energy1.48%
Other2.21%

Behavioral investing profile

Checking access…
Diversified Scout
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track RecordNo data
Conviction41
Concentration21
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
AR03945R110ARCHER AVIATION INC
Q2 2025 Q2 2026+454,385 shares-$1.2M
5Q
EC278768AB2ECHOSTAR CORP
Q2 2025 Q2 2026+101.4M shares+$439.7M
5Q
MCDMCDMCDONALDS CORP
Q2 2025 Q2 2026+50,883 shares+$13.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used